Myocardial infarction • Macrophage polarization • N-propargyl caffeamide (PACA) • Inducible nitric oxide synthase (iNOS) • Heme oxygenase-1 (HO-1) Abstract Background/Aims: Macrophages exhibit dynamic pro-inflammatory and resolving activities in myocardial infarction. The present study investigated whether caffeic acid derivatives could induce macrophage polarization towards a resolving M2 phenotype against myocardial infarction injury. Methods: Western blotting, RT-PCR and flow cytometry techniques are used to evaluate macrophage biomarkers expression and specific proteins in the related signaling pathways. Ligation of the left anterior descending artery induced rat model of myocardial infarction, TTC staining and immunohistochemical staining are used to examine cardioprotective effect in vivo. Results: We initially evaluated the anti-inflammatory activity of four caffeic acid derivatives including n-propargyl caffeamide (PACA) in RAW264.7 macrophages. As result, PACA selectively suppressed the up-regulation of inducible nitric oxide synthase (iNOS) over cyclooxygenase-2 (COX-2) in lipopolysaccharides (LPS)-stimulated cells. We subsequently examined the effects of PACA on macrophage polarization by determining macrophage biomarkers. PACA down-regulated M1 biomarkers (e.g., iNOS, tumor necrosis factor-α (TNF-α), C-X-C motif chemokine 10 (CXCL10) and CD80) but upregulated M2 biomarkers (e.g., Ym-1 and arginase-1). On the other hand, PACA suppressed macrophage chemotaxis while enhanced macrophage phagocytosis. We further examined the in vivo cardioprotective activity of PACA in a rat model of myocardial infarction. Following ligation of the left anterior descending artery, PACA treatment effectively reduced myocardial infarct size and promoted macrophage M2 polarization. We finally explored the underlying mechanisms. We found that PACA attenuated LPS-induced NF-ĸB activation while activated Nrf2/HO-1 pathway. HO-1 inhibitor SnPP attenuated the effects of PACA on iNOS expression in LPS-challenged macrophages, possibly by regulating the cross-talk between HO-1 and NF-ĸB pathways. Conclusions: The key finding from the present study was that PACA promoted timely switch of macrophage phenotypes from pro-inflammatory M1 to resolving M2. We anticipate that PACA is a potential drug candidate for the resolution of inflammation and cardiac repair after myocardial infarction.
Introduction
Myocardial infarction causes ischemic necrosis of heart tissues, a leading cause of human death [1] . Upon infarction, proinflammatory immune cells especially polymorphonuclear leukocytes/monocytes are rapidly recruited to the hearts. Infiltrating neutrophils and macrophages are activated to induce inflammatory responses, oxidative stress, and uncontrolled deposition of extracellular matrix components [2] . Depending on the pathological conditions, macrophages undergo dynamic M1/M2 polarization in infarcted hearts [3] . Proinflammatory M1 macrophages produce a battery of proinflammatory mediators including interleukin 6 (IL-6) and tumor necrosis factor-α (TNF-α) [4] . Macrophages also exhibit an anti-inflammatory and resolving M2 phenotype for resolving post-infarct inflammation and repairing cardiac tissues [4, 5] . The phenotypes of macrophage are defined by the expression pattern of specific biomarkers [4] . Inducible nitric oxide synthase (iNOS) is well-recognized as a key M1 biomarker and induced by several pro-inflammatory cytokines and lipid mediators [6] . In response to inflammatory stimuli, nuclear factor-kappa B (NF-κB) pathway is activated to up-regulate iNOS expression, leading to the overproduction of toxic NO [7] . In contrast, M2 macrophages express lower level of iNOS but higher level of arginase-1 (Arg1) [8] . The iNOS/Arg1 ratio is widely used to define macrophage M1 or M2 polarization. Nevertheless, timely switch from M1 to M2 macrophage profile is critical for the resolution of inflammation and the recovery of cardiac functions in myocardial infarction [9] .
Macrophage differentiation and plasticity are under the control of the microenvironment within the pathological contexts [10] . It is now known that pharmacological interventions with antioxidant and anti-inflammatory agents promote M2 macrophage polarization [11, 12] . Interestingly, heme oxygenase-1 (HO-1) is often activated to provide endogenous persistence against oxidant, inflammatory and immunomodulatory stimuli [13] . HO-1 catalyzes the degradation of pro-oxidant heme into three important antioxidant products, bilirubin, carbon monoxide (CO) and ferrous ion. These products activate different mechanisms to contribute to the pharmacological activities of HO-1 [13, 14] . Consequently, HO-1 activation inhibits mast cell degranulation and cytokine synthesis in several inflammatory disease models [15, 16] . By mimicking HO-1 activation, CO-releasing molecules (CORMs) was recently evaluated for anti-inflammatory potential in different in vitro and in vivo models [17] . Along this line, we attempted to demonstrate the pharmacological activation of HO-1 pathway as a new anti-inflammatory strategy [18] [19] [20] .
Natural products represent a rich source for the discovery of anti-inflammatory agents and immunomodulators [21] . As an example, caffeic acid is widely present in a variety of fruits and medicinal plants [22] . Caffeic acid and its derivatives (e.g., caffeic acid phenethyl ester (CAPE) and octyl caffeate) have anti-oxidant, anti-inflammatory, neuroprotective and anti-cancer activities [23] . Recent studies suggest that caffeic acid and its derivatives have cardioprotective potential against myocardial infarction injury [24, 25] . However, it remains elusive whether and how caffeic acid derivatives affect the functions of macrophages.
In the present study, we investigated a small panel of caffeic acid derivatives including in-house synthesized n-propargyl caffeamide (PACA) and n-propyl caffeamide (PCA) for the potential to regulate macrophage M1/M2 polarization in a rat model of myocardial infarction. We also investigated the potential underlying mechanisms by focusing on the Nrf2/HO-1 and NF-κB pathway.
Materials and Methods
Chemicals and reagents PACA and N-propyl caffeamide (PCA) were synthesized and characterized by NMR and MS as a previous method [19, 26] . Propyl caffeate (PCE) was synthesized by Hangzhou Yuhao chemical Technology Co., Ltd (Hangzhou, China). Antibodies against extracellular-signal-regulated kinase 1/2 (ERK1/2), p38, c-Jun N-terminal kinase (JNK), phospho-ERK1/2, phospho-p38, phospho-JNK, iNOS, cyclooxygenase-2 (COX-2) and glyceraldehydes-3-phosphate dehydrogenase (GAPDH) were obtained from Cell Signaling Technology (Boston, MA, USA). HO-1 antibody was purchased from Enzo Life Sciences (Farmingdale, New York, USA). The antibodies against Nrf2, NF-κB p65 subunit, Arg1, ED2 and lamin B were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Antibody against CD68 and ED1 were purchased from Abcam (Cambridge, Massachusetts, USA). FITC-labeled anti-mouse CD80 antibody was obtained from BD biosciences (BD Biosciences, San Diego, CA, USA). Alexa Fluor 594-conjugated goat anti-rabbit IgG antibodies and Alexa Fluor 488-conjugated goat anti-mouse IgG antibodies were purchased from Life technologies (Carlsbad, CA, USA). HRP-conjugated anti-rabbit IgG secondary antibody and other chemicals were obtained from Sigma-Aldrich (St. Louis, MO, USA).
Cell culture and drug treatment
Murine macrophage cell line RAW264.7 was maintained in Dulbecco's Modified Eagle Medium (DMEM) containing 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin (Invitrogen, Carlsbad, CA, USA) at 37 °C in a 5% CO 2 humidified atmosphere. For drug treatment, the cells at 70-80% confluence in the complete growth medium were treated with caffeic acid derivatives at the indicated concentrations for specified times, whereas the control cells were treated with equal volume of dimethyl sulfoxide (DMSO) under the same conditions. For Western blot analysis, the cells were pre-treated with drugs for 2 h and cotreated with LPS for another 24 h.
Measurement of cell viability
The cell viability was evaluated by a standard colorimetric assay using 3-[4, 5-dimethylthiazol-2-yl]-2, 5-diphenyltetrazolium bromide (MTT) as previously described [27] . Briefly, the cells were treated with caffeic acid derivatives at the indicated concentrations for the indicated times. Cell culture medium was removed, and subsequently the cell monolayers were incubated with 0.5 mg/ml MTT in phosphate-buffered saline (PBS) for 4 h. The purple formazan product was dissolved in 100 μl of DMSO and measured for the absorbance at 570 nm on a Bio-Rad microplate reader (Hercules, CA, USA). The cell viability was presented as a percentage to that of vehicle-treated controls.
Reverse transcription polymerase chain reaction (RT-PCR) analysis
Following the treatment with caffeic acid derivatives, the total RNAs were isolated with TRIzol reagent following the manufacture's instruction (Invitrogen, CA, USA). The cDNAs were prepared using SuperScript III reverse transcriptase and oligo primers (Thermo, Waltham, MA, USA) as previous described [28] forward, 5'-ATGGATGACGATATCGCTGC-3' reverse, 5'-TTCTGACCCATTCCCACCATC-3' PCR amplifications were performed under the control of the following program: 1) denaturation, 94˚C for 3 min; 2) reactions, 30 cycles of 94˚C for 30 sec, 60˚C for 30 sec, and 72˚C for 1 min; 3) extension, 72˚C for 10 min. PCR products were analyzed by gel electrophoresis in 2% agarose containing GelRed nucleic acid stain (Biotium, Hayward, CA, USA) and visualized under a UV light illuminator.
Western blot analysis
Following drug treatment, the cellular proteins were prepared and analyzed by Western blotting analysis for protein expression as previously described [29] . Briefly, the cellular proteins were prepared and resolved by electrophoresis on 10% SDS-polyacrylamide gels and transferred onto a polyvinylidenedifluoride (PVDF) membrane. After overnight incubation in 5% BSA in Tris-buffered saline with 0.1% Tween-20 (TBST), the membranes were probed with specific primary antibodies, and subsequently detected by goat anti-rabbit or goat anti-mouse IgG-HRP conjugate secondary antibodies. The activity of peroxidase retained on the blots was visualized with enhanced chemiluminescence (ECL) detection reagents from GE Healthcare (Uppsala, Sweden) according to the manufacturer's instruction.
Cell immunofluorescence staining
Upon the completion of drug treatment, the cells were fixed with 4% paraformaldehyde in PBS for 30 minutes, permeabilized with 0.5% Triton X-100 for 10 minutes and blocked in 5% normal goat serum in PBS for 1 h at room temperature. The cells were probed with anti-Nrf2 or anti-p65 antibodies, and subsequently detected by Alexa Fluor 594-conjugated goat anti-rabbit IgG secondary antibody. Following staining the cell nuclei with DAPI, the immunofluorescent images were captured on a Zeiss fluorescence microscopy (Jena, Germany).
Measurement of NO level
The production of intracellular NO was evaluated by staining with DAF-FM diacetate from Invitrogen (Eugene, OR, USA) according to the manufacturer's instruction. Briefly, at the end of drug treatment, the cells were incubated with DAF-FM diacetate. The images were captured under a Zeiss fluorescence microscope (Jena, Germany). The intracellular NO levels were presented as a percentage to that of the vehicle controls using NIH Image J software (http://imagej.nih.gov/ij/).
Flow cytometry RAW 264.7 macrophages were pretreated with 10 μM PACA, and then co-stimulated by LPS (1 μg/mL) and IFN-γ (0.5 μg/mL) for 24 h. After the treatment, the cells were collected and stained with fluorescenceconjugated marker CD80. Flow cytometric analysis was carried out on a BD LSR Fortessa Analyzer (BD Biosciences, San Jose, CA). The results were analyzed with FlowJo software (Tree Star, Ashland, OR).
Assay of macrophage chemotaxis
Macrophage chemotaxis was measured in a 12-well Transwell plate according to the manufacturer's introduction [30] . RAW264.7 cells were treated with vehicle, LPS and LPS plus caffeic acid derivatives for 24 h. To generate the conditioned medium, H9c2 cells were challenged under OGD conditions for 12 h. The cell culture medium was recovered as the OGD-conditioned medium, and subsequently transferred to the lower chamber of Transwell plate [31] . Drug-treated RAW264.7 cells were added to the upper chamber (10 5 cells/ well), and allowed to transmigrate over a period of 4 h. The cells that migrated through a polycarbonate membrane with a pore size of 5 μm were fixed by methanol for 20 min. The cells in the insert were removed by wiping the microporous membrane with cotton swab. The membranes were then stained with 0.1% crystal violet for 15 min and washed with PBS. Finally, the membranes were carefully placed on the glass slide for microscopy observation and imaging. At the end of imaging, the membranes were incubated with 30% glacial acetic acid for the quantification of macrophages at the wavelength of 570 nm.
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Phagocytosis of latex beads and apoptotic H9c2 cells
For phagocytosis of latex beads, FluoSpheres® carboxylate-modified beads with the particle size of 1.0 μm (Life Technology, NY, USA) were pre-incubated with 10% FBS/PBS for 1 h at 37 ℃, and then added into RAW264.7 cell culture at 10:1 ratio. Phagocytosis was assessed over a period of 1.5 h. Non-adherent beads were washed away by cold-PBS, whereas the cells were stained with CellTracker, Orange CMTMR probe (Life Technology, NY, USA). For phagocytosis of apoptotic H9c2 cells, H9c2 cells were challenged under OGD conditions for 12 h for the induction of cell apoptosis. Apoptotic H9c2 cells were labeled with CellTracker,Green CMTMR probe (Life Technology, NY, USA) and subsequently incubated with RAW264.7 macrophages at 10:1 ratio at 37℃ for another 1.5 h. After non-adherent cells were removed, RAW 264.7 cells were stained with CellTracker, Orange CMFDA probe (Life Technology, NY, USA). All slides were examined on a Zeiss laser scanning microscope (Carl-Zeiss, Jena, Germany).
Induction of myocardial infarction in rats
All experiments and methods were carried out following the IACUC guidelines. The experimental procedures were approved by the Animal Care Committee of the University of Hong Kong. Prior to animal experiments, PACA was dissolved in 0.9% saline containing 5% ethanol as a stock solution (150 mg/ml). Thirty-two male Sprague-Dawley rats were randomly assigned to Sham group and surgery group in 1:3 ratio. Rat model of myocardial ischemia reperfusion was induced by the ligation of the left anterior descending (LAD) artery. In practical, the surgery procedure was carried out as follows: rats were anesthetized with ketamine (90 mg/kg) plus xylazine (10 mg/kg) and ventilated through a small animal volume-control ventilator at 95 breaths and 1.8 mL volume. The chest was opened between the 3 rd and 4 th rib. Following the thoracotomy, rat hearts were exposed, and the LAD artery was subsequently ligated with a 6-0 silk suture. At the end of surgery, the chest was closed. Rats in sham group were subjected to the same surgical procedures except for LAD artery ligation. For drug treatment, at 24 h after LAD artery ligation, MI group received i.p. injection of vehicle (0.5 ml/day) for 3, 5 or 7 days; MI+PACA group received i.p. injection of PACA (15 mg/ kg/day) for 3, 5 or 7 days; Sham group received i.p. injection of vehicle (0.5 ml/day) for 3, 5 or 7 days; At the end of experiments, 1% Evans blue dye was injected and rat hearts were quickly collected, frozen, and cut into 2 mm-sections. Five sections from each rat were incubated in 1% TTC at 37 °C for 15 min, and fixed in 4% formalin solution. The infarct area (IA, white color or yellow color) and area at risk (AAR, red, white and yellow color) were assessed. AAR and IA were measured by computerized planimetry using NIH Image J software.
Histopathological examination
The histopathological examination was conducted as previously described [32] . In brief, at the end of drug treatment as indicated, animals were euthanized. Cardiac samples were collected and fixed in 4% paraformaldehyde in PBS (Sigma, St. Louis, MO, USA). Paraffin-embedded sections (5-μm) were prepared and stained with hematoxylin and eosin (H&E) stain. H&E stained sections were imaged and examined under light microscope for gross myocyte injury and the effect of interventions
Immunohistochemistry staining
Heart tissues were embedded in paraffin wax and processed into 5-μm thin slices. Following deparaffinization and rehydration, tissue sections were subjected to antigen retrieval in 0.01 M citrate buffer (pH 6.0) in a microwave oven. Tissue sections were subsequently blocked with 5% goat serum in TBS-T buffer, and probed with primary antibodies against ED1 and ED2 overnight. The antibodies retained on the sections were detected with the corresponding secondary antibodies at room temperature for 90 min. The slides were imaged on a Zeiss microscopy (Carl-Zeiss, Jena, Germany). The ED1 and ED2 positive cells were counted from five different pictures from one slide. And the results were derived from three heart tissue slides from three different rats.
Statistical analysis
The results were presented as means ± SD or means ± SEM from three or more independent experiments. Statistical analysis was performed by one-way analysis of variance (ANOVA) with post hoc Fisher's least significant difference (LSD) test, Dunnett's test or Student's t-test using SPSS software 20.0. A p-value of < 0.05 was considered as statistically significant. 
Results
Caffeic acid derivatives differently regulated the expression of iNOS and COX-2 against LPS challenge
We initially examined the effects of caffeic acid (CA) and four derivatives on the growth of RAW264.7 macrophages. The IC50 concentrations of these compounds were calculated as follows: 642.5 μM, CA; 262.0 μM, PACA; 92.7 μM, PCA; 54.2 μM, PCE and 10.6 μM, CAPE. We selected the sub-toxic concentration of 10 μM for these caffeic acid compounds for the treatment of cell culture. RAW264.7 macrophages were pre-treated with caffeic acid compounds and challenged with LPS. We examined the effects of five compounds on the induction of iNOS and COX-2 in LPS-stimulated RAW264.7 macrophages by Western blotting. As shown in Fig. 1A . PCE, PCA and PACA showed strong inhibitory effects on iNOS induction and no much effects on COX-2 induction against LPS stimulation. As an exception, CAPE abolished the stimulatory effects of on the induction of iNOS and COX-2 expression. By taking the potency and cytotoxicity into account, we further examined whether the concentrations (e.g., 0, 10, 20 and 50 μM) of PACA affected the expression of iNOS and COX-2 in LPS-stimulated Fig. 1B , PACA selectively attenuated the stimulatory effects of LPS on the expression of iNOS in a concentration-dependent manner but did not change COX-2 expression. Consistently, PACA dramatically diminished LPS-induced production of the intracellular NO species in a concentration-dependent manner (Fig. 1C) .
Caffeic acid derivatives altered the expression profiles of macrophage M1 and M2 biomarkers
To investigate the effects of caffeic acid derivatives on macrophage polarization, we determined several well-recognized macrophage biomarkers by RT-PCR or flow cytometric analysis. As shown in Fig. 1D , LPS increased the mRNA levels of M1 biomarkers (e.g., TNF-α, CXCL10 and iNOS) in RAW264.7 macrophages. PACA, PCA and PCE effectively suppressed the upregulation of the mRNAs for M1 biomarker against LPS stimulation. PACA showed the strongest inhibition, whereas CA and CAPE exhibited much less activity. On the other hand, PACA markedly upregulated the expression of Ym-1 mRNA and Arg1 mRNA, whereas PCA, PCE, CAPE and CA failed to increase the expression of these M2 biomarker mRNAs. We further verified the effect of PACA on the expression of M1 biomarker CD80 by flow cytometry. Fig.  1E showed that PACA effectively reduced the population of CD80 + M1 macrophages from 77.8% to 66.3% in response to LPS and IFN-γ.
Caffeic acid derivatives inhibited macrophage chemotaxis
To examine the effects of caffeic acid derivatives on the functions of macrophages, we first investigated the effects of caffeic acid derivatives on macrophage chemotaxis towards apoptotic cardiomyocytes by Transwell migration assay as previously described [33] . Rat cardiomyocyte H9c2 cells were challenged under oxygen glucose deprivation (OGD) conditions to undergo apoptosis. The cell culture medium was collected as the conditioned medium and placed in the lower chambers in a Transwell plate. Following the treatment Effects of caffeic acid derivatives on the chemotactic potential of RAW264.7 macrophages. After the treatment with caffeic acid derivatives and LPS for 24 h, the cell culture medium was collected as the conditioned medium for the assay of chemotactic potential in Transwell plates. Fresh macrophages that migrated towards the conditioned medium were fixed, stained and imaged under a microscope. Representative images were shown. Macrophage migration was quantified by measuring the absorbance of cell extracts as described in "Experimental methods". The results were expressed as Means ± SD (n = 3). a, p<0.05; b, p<0.01 (Drug + LPS vs LPS alone); #, p<0.05 (Drug vs vehicle). (B) Effects of caffeic acid derivatives on the phagocytosis of latex beads by macrophages. After 24 h treatment with caffeic acid derivatives and LPS, RAW264.7 macrophages were stained with CellTracker Orange CMTMR dye, and subsequently incubated with FITC-labeled beads for 1.5 h. The images were acquired on a fluorescence microscope and analyzed with NIH Image J software. (C) Effects of caffeic acid derivatives on the phagocytosis of apoptotic H9c2 cells. After the treatment with caffeic acid derivatives and LPS for 24 h, RAW264.7 macrophages were labeled with CellTracker Orange CMTMR dye. H9C2 cells were driven to undergo apoptosis by OGD exposure for 12 h and labeled with CellTracker Green CMTMR dye. After labeling, RAW264.7 macrophages and apoptotic H9C2 cells were incubated for 1. with caffeic acid derivatives and LPS as described in Methods, RAW264.7 macrophages were evaluated for migration through Transwell membrane from the upper chamber. By counting macrophages that migrated through Transwell membrane, as shown in Fig. 2A , LPS enhanced macrophage migration by up to 1.8-fold compared with untreated control. Caffeic acid derivatives effectively attenuated the stimulatory effect of LPS on macrophage chemotaxis. Particularly, PACA showed the strongest inhibition on LPS-induced chemotaxis of macrophages.
Caffeic acid derivatives enhanced macrophage phagocytosis
As for macrophage functions, we subsequently examined the effect of caffeic acid derivatives on macrophage phagocytosis. The first experiment was to assay the phagocytosis of latex beads. RAW264.7 cells were labeled with CellTracker™ Orange CMTMR probe prior to the incubation with FITC-labeled latex beads with the size of 1.0 μm. As shown in Fig. 2B , PACA and PCA promoted the binding of latex beads onto macrophages and further enhanced the stimulatory effects of LPS on macrophage phagocytosis. PCE and CA only enhanced the effects of LPS on macrophage phagocytosis. CAPE did not show much effect on macrophage phagocytosis possibly due to its cytotoxicity. The second experiment was to assay the phagocytosis of apoptotic cardiomyocytes. H9c2 cells were challenged under OGD conditions to induce apoptosis. Apoptotic H9c2 cells were subsequently labeled with CellTracker™ Green CMTMR probe whereas RAW264.7 macrophages stained with CellTracker™ Orange CMFDA probe after drug treatment. As shown in Fig. 2C , PACA not only increased the binding of H9c2 cells to macrophages and but also enhanced the effects of LPS on macrophage phagocytosis. Other drugs except for CAPE only enhanced the effects of LPS on macrophage phagocytosis. 
PACA protected hearts against ischemia-induced cardiac injury
To evaluate the in vivo cardioprotective efficacy of PACA, we induced myocardial infarction in rats by ligating LAD artery as previously described [34] . PACA was administered via i.p. injection at 24 h after artery ligation. Based on TTC staining in Fig. 3B , PACA reduced myocardial infarct size on Day 3 from 34.5 % to 15.0 %. As shown in Fig. 3C , H&E staining identified the disruption of myofibrillar structure and the accumulation of neutrophil/ macrophage clusters in the ischemic myocardium. PACA at the dose of 15 mg/kg not only preserved myofibrillar structure but also reduced the recruitment of inflammatory cells and myolysis.
PACA skewed macrophage polarization from M1 to M2 phenotype in infarcted hearts
To define the phenotypes of cardiac macrophages, we stained macrophage M1 biomarker ED1 and M2 biomarker ED2 with specific antibodies. As shown in Fig. 3D and 3E, ED1 + M1 macrophages were barely detectable in control group, but markedly increased in MI group. PACA effectively decreased the number of ED1 positive cells. On the other hand, ED2 + M2 macrophages were barely detected in control group as well as MI group. PACA effectively increased the number of ED2 + M2 macrophages.
PACA did not attenuate LPS-induced activation of MAP kinases
To explore the potential mechanisms, we first examined the effect of PACA on LPSinduced activation of MAP kinases (e.g., ERK1/2, p38 and JNK). As shown in Fig. 4A , LPS dramatically induced the phosphorylation of ERK1/2, P38 and JNK. PACA barely affected such activities of LPS against MAP kinases. 
PACA exhibited the anti-inflammatory activities via activating the Nrf2/HO-1 pathway
To study the regulation of iNOS induction, we tentatively investigated the effects of PACA on LPS-induced activation of NF-κB pathway. By immunostaining and Western blotting of NFkB p65 subunit, we found that PACA effectively inhibited LPS-induced nuclear translocation of NF-kB p65 subunit (as shown in Fig. 4B and 4C) . We focused on the effects of PACA on the Nrf2/HO-1 pathway by immunostaining and Western blot analysis with specific antibodies. Following the treatment with PACA, the intracellular Nrf2 in macrophages was probed with Nrf2 antibody. As indicated in Fig. 4D , PACA strongly induced the nuclear translocation of Nrf2. Western blot analysis in Fig. 4E and 4F also showed that PACA induced HO-1 expression in a concentration and time-dependent manners.
To clarify the impact of HO-1 induction on the anti-inflammatory activities of PACA, we employed HO-1 specific inhibitor Sn(IV) protoporphyrin IX dichloride (SnPP) to block the enzyme activity of HO-1, and subsequently examined NF-kB activation, iNOS induction and HSC recruitment. Following the treatment with LPS alone or in combination with PACA and SnPP, macrophages were probed with antibody against NF-ĸB p65 subunit. As shown in Fig. 5A and 5B, HO-1 inhibitor SnPP attenuated the inhibitory effect of PACA on LPSinduced nucleus translocation of NF-ĸB p65 subunit. Western blot analysis in Fig. 5C and 5D suggested that HO-1 inhibitor dramatically recovered LPS-induced expression of iNOS and COX-2. PACA effectively attenuated LPS-induced expression of iNOS over COX-2. HO-1 inhibitor SnPP almost abolished the effect of PACA on LPS-induced expression of iNOS but showed no activity against COX-2 expression.
Discussion
Our previous studies not only synthesized PACA and PCA but also evaluated several caffeic acid derivatives for cardioprotective, neuroprotective and neurotrophic activities [19, 26] . The aim of the present study was to further examine the effects of caffeic acid derivatives on the phenotypes and functions macrophages in myocardial infarction. Our pilot studies suggested that PACA and analogs differentially attenuated iNOS expression over COX-2 expression in LPS-stimulated macrophages. Thus, we hypothesized that PACA might regulate macrophage polarization against myocardial infarction. Our work led to three key findings as follows: 1) PACA effectively promoted macrophage polarization towards a resolving M2-phenotype; 2) PACA reduced myocardial injury in a rat model of myocardial infarction.; 3) PACA mainly regulated two key redox sensitive signaling pathways, namely Nrf2/HO-1 pathway and NF-kB pathway.
Inflammation is an important therapeutic target for the treatment of myocardial infarction [1] . The existing anti-inflammatory drugs are mainly designed to target the production of proinflammatory mediators such as NO, PGE2, TXA2, TNF-α and IL-1β via regulating ERK, p38, JNK, NF-kB and Nrf2 [35] [36] [37] . In the present study, we found that PACA exhibited selective activity against iNOS up-regulation and NO overproduction in LPSstimulated macrophages, while showed no activity against COX-2 expression. To elucidate the underlying mechanisms, we firstly investigated the effects of PACA on the activation of MAP kinases (i.e., ERK, p38 and JNK) and the nuclear translocation of NF-kB. Surprisingly, PACA did not affect the phosphorylation of ERK, p38 and JNK. LPS and many other proinflammatory stimuli are known to activate the NF-κB pathway for regulating the expression of immunomodulating and inflammatory genes [38] . NF-κB activation is a complex process involving rapid phosphorylation and degradation of IκB. Ultimately, NF-kB p65 and p50 subunits are translocated to the cell nucleus and induce iNOS and COX-2 in an equally effective manner [39, 40] . Based on Western blotting and immunostaining, we found that PACA reduced the nuclear translocation of NF-kB in LPS-stimulated macrophages. These results suggest that inhibition of NF-κB pathway is only part of the mechanisms by which PACA selectively suppresses the expression of iNOS over COX-2.
To further clarify the selective effects of PACA on iNOS expression, we focused on the antioxidant Nrf2/HO-1 pathway. Nrf2 is a redox sensitive transcriptional factor and regulates the cellular defense against oxidative stress [41] . Oxidative stressors and some anti-inflammatory electrophilic drugs disrupt Keap1-Nrf2 complex, promote the nuclear translocation of Nrf2 and finally activate the transcription of antioxidant genes including HO-1 [42] . We have previously identified several botanicals (e.g., Z-ligustilide, senkyunolide H, senkyunolide I, puerarin, PACA) for activating the Nrf2-Keap1 pathway and inducing HO-1 expression [18] [19] [20] 43] . In the present study, therefore, we hypothesized that PACA might regulate iNOS induction and macrophage M2 polarization via activating Nrf2/HO-1 pathway. HO-1 is well-known to orchestrate the cross-talks between Nrf2 and NF-kB pathways [14, 44, 45] . Thus, we further examined whether HO-1 inhibitor SnPP could affect the activity of PACA. Indeed, PACA induced HO-1 expression in RAW264.7 macrophages in a concentrationand time-dependent manner. HO-1 specific inhibitor SnPP diminished the inhibitory effect of PACA on NF-κB activation and iNOS induction in LPS-stimulated macrophages. These results suggest that PACA activates Nrf2/HO-1 as the key mechanism for inhibiting NF-κB pathway and subsequently down-regulating LPS-induced iNOS expression.
The overexpression of iNOS is strongly associated with M1 macrophage polarization [46] . In the present study, we identified the selectivity of caffeic acid derivatives (e.g., PACA, PCA and PCE) against LPS-induced iNOS expression over COX-2 expression. We further clarified whether caffeic acid derivatives could modulate the phenotypic and functional switch of macrophages. Our results demonstrated that PACA and other caffeic acid derivatives not only reduced the expression of M1 biomarkers (e.g., iNOS, TNF-α, CXCL10) but also increased the expression of M2 biomarkers (e.g., Arg1, Ym-1 [47] [48] [49] [50] . Macrophage polarization was modulated by several signaling pathways, such as PKA-STAT3, TLR4 and so on [51, 52] . Thus, PACA may promoting macrophage M2 polarization for the resolution of inflammation, clearance of debris and tissue healing.
In conclusion, the present study demonstrated that PACA and other caffeic acid derivatives could promote macrophage polarization from proinflammatory M1 to antiinflammatory/resolving M2 phenotype. The present study also discovered that PACA might exhibit cardioprotective potential via activating Nrf2/HO-1 pathway and inhibiting NF-κB pathway (Fig. 5D) . Therefore, we anticipate that PACA is a promising drug candidate for the therapy of myocardial infarction.
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